1. Medtech Insight

Siemens Healthineers In Line With Future Trends As It Mines Workflow And Outcomes Seams

 
• By Ashley Yeo

Siemens Healthineers  ̶  an engineering company by background – sees itself well positioned to benefit from the markets’ movement towards digital, workflows, robotics and minimally-invasive procedures. As such, it has advantages over pharma companies in being able to deliver better patient outcomes at lower cost and more effectively.

MRI

Siemens Healthineers might be forgiven for congratulating itself on its track record and upwards trajectory in its three business segments less than two years after its March 2018 IPO and establishment as a stand-alone manufacturer. The €14.5bn ($16.2bn) revenues company retains the innovation-driven culture of the wider Siemens group, and shares its business code, but is now both more mobile and visible as a health-care player.

Addressing Jefferies Healthcare delegates, Healthineers’ CFO Jochen Schmitz said that that company has a very real and clear purpose, now that it is split away from the Siemens group. There...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.